Business
UNIVERSAL IBOGAINE Engages Investor Relations Firm Blue Digital Media
(TheNewswire) Calgary, AB – TheNewswire - June 13, 2022 ...
About this update from Universal Ibogaine Inc
[{"type":"text","content":"UNIVERSAL IBOGAINE Engages Investor Relations Firm Blue Digital Media\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n Calgary, AB –\n \n \n TheNewswire\n-\n \n \n June 13, 2022\n \n \n \n –\n \n \n \n \n Universal Ibogaine Inc.\n \n \n \n \n (TSXV:IBO\n \n \n \n \n )\n \n \n \n \n ,\n \n \n \n \n (\n \n \n \n \n OTC:IBOGF\n \n \n \n \n )\n \n \n \n \n and\n \n \n \n \n (\n \n \n \n \n FSE:JC4) (“\n \n \n \n \n UI\n \n \n \n \n ” or the “\n \n \n \n \n Company\n \n \n \n \n ”) a life sciences company with a mission to\ntransform addiction treatment through the use of medicalized ibogaine\nand a global licensing model advises it has engaged investor\ncommunications firm Blue Digital Media & Web Solutions\n(“\n \n \n \n \n Blue\nDigital\n \n \n \n \n ”) for assistance\nwith expanding awareness of UI’s business activities.\n \n \n \n \n \n Blue Digital will provide expanded\n \n \n distribution of the UI story across multiple channels and\naudiences.  The expected result is increased awareness of UI’s\n plans for research into utilizing ibogaine as part of the delivery\nof a continuum of care treating opioid abuse and other\naddictions.\n \n \n \n \n Blue Digital will receive compensation of USD 27,000\nfor a 3 month engagement effective June 13, 2022.  In addition, Blue\nDigital will receive a total of 450,000 stock options to purchase\ncommon shares of the Company, with an exercise price of $0.10 per\nshare, a term of 3 years to expiry, and vesting one-third at the end\nof each month of the term of service.\n \n \n \n \n Nick Karos, UI’s Chief Executive Officer, noted “We\nare pleased to have access to Blue Digital’s distribution channels,\nas their reach across borders will expand awareness of our business\nto new audiences. Addiction knows no boundaries and so the solution\nwe pursue must also be global in nature.”\n \n \n \n \n \n About Universal\nIbogaine Inc.\n \n \n \n \n \n \n UI is a life sciences company,\n \n \n \n \n with a mission to\ntransform addiction treatment using medicalized ibogaine through a\nplanned Canadian clinical trial focused on opioid use disorder, and\nultimately to utilize that protocol globally through planned future\nlicensing agreements.\n \n \n \n \n UI is concurr...